Literature DB >> 35084215

Nrf2 attenuates hyperglycemia-induced nNOS impairment in adult mouse primary enteric neuronal crest cells and normalizes stomach function.

Chethan Sampath1, Abhinav V Raju2, Michael L Freeman3, Shanthi Srinivasan2,4, Pandu R Gangula1.   

Abstract

Enteric neuronal cells play a vital role in gut motility in humans and experimental rodent models. Patients with diabetes are more vulnerable to gastrointestinal dysfunction due to enteric neuronal degeneration. In this study, we examined the mechanistic role and regulation of nuclear factor-erythroid 2-related factor 2 (Nrf2) in hyperglycemia-induced enteric neuronal cell apoptosis in vitro by using adult mouse primary enteric neuronal crest cells (pENCs). Our data show that hyperglycemia (HG) or inhibition of Nrf2 induces apoptosis by elevating proinflammatory cytokines, reactive oxygen species (ROS) and suppresses neuronal nitric oxide synthase (nNOS-α) via PI3K/Nrf2-mediated signaling. Conversely, treating pENCs with cinnamaldehyde (CNM), a naturally occurring Nrf2 activator, prevented HG-induced apoptosis. These novel data reveal a negative feedback mechanism for GSK-3 activation. To further demonstrate that loss of Nrf2 leads to inflammation, oxidative stress, and reduces nNOS-mediated gastric function, we have used streptozotocin (STZ)-induced diabetic and Nrf2 null female mice. In vivo activation of Nrf2 with CNM (50 mg/kg, 3 days a week, ip) attenuated impaired nitrergic relaxation and delayed gastric emptying (GE) in conventional type 1 diabetic but not in Nrf2 null female mice. Supplementation of CNM normalized diabetes-induced altered gastric antrum protein expression of 1) p-AKT/p-p38MAPK/p-GSK-3β, 2) BH4 (cofactor of nNOS) biosynthesis enzyme GCH-1, 3) nNOSα, 4) TLR4, NF-κB, and 5) inflammatory cytokines (TNF-α, IL-1β, IL-6). We conclude that activation of Nrf2 prevents hyperglycemia-induced apoptosis in pENCs and restores nitrergic-mediated gastric motility and GE in STZ-induced diabetes female mice.NEW & NOTEWORTHY Primary neuronal cell crust (pENCs) in the intestine habitats nNOS and Nrf2, which was suppressed in diabetic gastroparesis. Activation of Nrf2 restored nNOS by suppressing inflammatory markers in pENCs cells. Inhibition of Nrf2 reveals a negative feedback mechanism for the activation of GSK-3. Activation of Nrf2 alleviates STZ-induced delayed gastric emptying and nitrergic relaxation in female mice. Activation of Nrf2 restored impaired gastric BH4 biosynthesis enzyme GCH-1, nNOSα expression thus regulating nitric oxide levels.

Entities:  

Keywords:  Nrf2; enteric neuronal cells; inflammation; nNOS; siRNA-Nrf2

Mesh:

Substances:

Year:  2022        PMID: 35084215      PMCID: PMC8897013          DOI: 10.1152/ajpgi.00323.2021

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  70 in total

1.  Toll-like receptor 4 gene Asp299Gly and Thr399Ile polymorphisms in type 2 diabetes mellitus: A meta-analysis of 15,059 subjects: Need for clarification of data in a recent meta-analysis.

Authors:  Wei-Wei Chang; Liu Zhang; Yue-Long Jin; Ying-Shui Yao
Journal:  Diabetes Res Clin Pract       Date:  2015-08-22       Impact factor: 5.602

Review 2.  Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway.

Authors:  Thomas W Kensler; Nobunao Wakabayashi; Shyam Biswal
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Nrf2 enhances cholangiocyte expansion in Pten-deficient livers.

Authors:  Keiko Taguchi; Ikuo Hirano; Tohru Itoh; Minoru Tanaka; Atsushi Miyajima; Akira Suzuki; Hozumi Motohashi; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2013-12-30       Impact factor: 4.272

Review 4.  Enteric neuropathy associated to diabetes mellitus.

Authors:  José Antonio Uranga-Ocio; Sonia Bastús-Díez; Drissa Delkáder-Palacios; Noemí García-Cristóbal; Miguel Ángel Leal-García; Raquel Abalo-Delgado
Journal:  Rev Esp Enferm Dig       Date:  2015-06       Impact factor: 2.086

5.  GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway.

Authors:  Mallappa Anitha; Chetan Gondha; Roy Sutliff; Alexander Parsadanian; Simon Mwangi; Shanthi V Sitaraman; Shanthi Srinivasan
Journal:  J Clin Invest       Date:  2006-02       Impact factor: 14.808

6.  Colonic motor dysfunction in human diabetes is associated with enteric neuronal loss and increased oxidative stress.

Authors:  B Chandrasekharan; M Anitha; R Blatt; N Shahnavaz; D Kooby; C Staley; S Mwangi; D P Jones; S V Sitaraman; S Srinivasan
Journal:  Neurogastroenterol Motil       Date:  2010-10-12       Impact factor: 3.598

7.  Deleterious effects of intestinal ischemia/reperfusion injury in the mouse enteric nervous system are associated with protein nitrosylation.

Authors:  Leni Rose Rivera; Michelle Thacker; Louise Pontell; Hyun-Jung Cho; John B Furness
Journal:  Cell Tissue Res       Date:  2011-02-09       Impact factor: 5.249

Review 8.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

9.  Hyperglycemia in streptozotocin-induced diabetes leads to persistent inflammation and tissue damage following uveitis due to reduced levels of ciliary body heme oxygenase-1.

Authors:  Settimio Rossi; Michele D'Amico; Annalisa Capuano; Mary Romano; Pasquale Petronella; Clara Di Filippo
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

Review 10.  Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment.

Authors:  Theresa Meldgaard; Søren Schou Olesen; Adam D Farmer; Klaus Krogh; Anne Astrid Wendel; Birgitte Brock; Asbjørn Mohr Drewes; Christina Brock
Journal:  J Diabetes Res       Date:  2018-09-16       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.